Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Ferrari

Showing results (11-20 of 818) with videos related to

Pageof 82
Sort By:
Pathologie-Biologie|April 1, 1992
Biochemistry of migraineM D Ferrari
Cephalalgia : an International Journal of Headache|October 18, 2001
Re: Gomez-Mancilla et al. Safety and efficacy of PNU-142633, a selective 5-HT(1D) agonist, in patients with acute migraine. Cephalalgia 2001;21:727-32M D Ferrari
European Neurology|May 28, 2005
Should we advise patients to treat migraine attacks early: methodologic issuesMichel D Ferrari
Headache|May 13, 2008
Migraine genetics: a fascinating journey towards improved migraine therapyMichel D Ferrari
Headache|April 23, 2002
Tripstar: a comprehensive patient-based approach to compare triptansMichel D Ferrari
Pharmacoeconomics|May 7, 1998
The economic burden of migraine to societyM D Ferrari
Cephalalgia : an International Journal of Headache|October 27, 2001
Sumatriptan by injectionM D Ferrari
Lancet (London, England)|April 18, 1998
MigraineM D Ferrari
Functional Neurology|January 21, 2009
Migraine as a process - challenges in the effective management of migraineM D Ferrari
European Neurology|January 1, 1996
The clinical effectiveness of 311C90 in the acute treatment of migraineM D Ferrari
Pageof 82

Showing results (11-20 of 818) with videos related to

Sort By:
Pageof 82
Pathologie-Biologie|April 1, 1992
Biochemistry of migraineM D Ferrari
Cephalalgia : an International Journal of Headache|October 18, 2001
Re: Gomez-Mancilla et al. Safety and efficacy of PNU-142633, a selective 5-HT(1D) agonist, in patients with acute migraine. Cephalalgia 2001;21:727-32M D Ferrari
European Neurology|May 28, 2005
Should we advise patients to treat migraine attacks early: methodologic issuesMichel D Ferrari
Headache|May 13, 2008
Migraine genetics: a fascinating journey towards improved migraine therapyMichel D Ferrari
Headache|April 23, 2002
Tripstar: a comprehensive patient-based approach to compare triptansMichel D Ferrari
Pharmacoeconomics|May 7, 1998
The economic burden of migraine to societyM D Ferrari
Cephalalgia : an International Journal of Headache|October 27, 2001
Sumatriptan by injectionM D Ferrari
Lancet (London, England)|April 18, 1998
MigraineM D Ferrari
Functional Neurology|January 21, 2009
Migraine as a process - challenges in the effective management of migraineM D Ferrari
European Neurology|January 1, 1996
The clinical effectiveness of 311C90 in the acute treatment of migraineM D Ferrari
Pageof 82